COVID-19 associated rhinomaxillary mucormycosis: a case series and review of literature
Braz. j. oral sci
;
21: e227017, jan.-dez. 2022. ilus
Article
in English
| LILACS, BBO
| ID: biblio-1393192
ABSTRACT
During COVID-19 pandemic, fulminant deep fungal infection started emerging in India, known as Mucormycosis. This type of mucormycosis was termed as COVID-19 associated mucormycosis (CAM). These patients had previous history of COVID-19 infection. Such cases were mainly reported in immunocompromised patients such as patients with poorly controlled diabetes and chronic renal diseases etc. Rhinomaxillary mucormycosis is an aggressive, fulminant, fatal deep fungal infection of head and neck region. Early diagnosis and prompt treatment can reduce the mortality and morbidity associated with the disease; hence we present case series of rhinomaxillary mucormycosis to create awareness amongst dental surgeons
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Signs and Symptoms
/
Comorbidity
/
Invasive Fungal Infections
/
COVID-19
/
Mucorales
/
Mucormycosis
/
Mycoses
Type of study:
Risk factors
/
Screening study
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Braz. j. oral sci
Journal subject:
Dentistry
Year:
2022
Type:
Article
Affiliation country:
India
Institution/Affiliation country:
KAHER's KLE VK Institute of Dental Sciences/IN
Similar
MEDLINE
...
LILACS
LIS